At the end of October, eight clinics told Reuters that the trial had been temporarily paused for new volunteers, with some clinics citing high demand and a shortage of doses. Reuters reporters saw queues of people waiting for a pre-vaccination medical examination at three Moscow trial clinics on Monday, Wednesday and Thursday. Vaccine developers intend to give the vaccine to 40,000 people initially. "The number of first shots was decreased to narrow the gap and to vaccinate more people with the second shot ... At the same time, a trial involving volunteers aged over 60 is continuing."

Source: bd News24 November 19, 2020 12:22 UTC